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Abstract
As a result of the radical changes that have taken place in pharmacy at the turn of the century, the role of pharmaceutical 
workers has acquired a fundamentally new meaning and development in the health care system of the countries. Under these condi-
tions, the issue of forming the human resources of pharmaceutical support systems acquires not only important professional signifi-
cance, but also acquires socio-economic content for the effective development of the macroeconomic complex of countries as a whole.
The aim. Carrying out a comparative analysis of the process of forming the human resources of pharmaceutical supply systems 
in Ukraine, Belarus, Poland, the countries of cooperation of the Independent States (CIS) and the European Region countries (ER) 
of the World Health Organization (WHO). 
Materials and methods. The indicators of the total number of graduates-pharmacists, as well as indicators of the number per 
100 thousand population in Ukraine, Belarus, Poland, the CIS and ER of WHO during 2000–2013 were studied. These indicators are 
presented on the European Health Information Portal. («Information and facts»). The authors used historical, information-analytical, ana-
lytical-comparative, systemic, logical, hypothetical-deductive and generalizations, as well as mathematical-statistical research methods.
Results. It is established that during 2000–2013 in Ukraine there was a significant increase in the number of graduates of 
pharmacists from 2.61 to 14.49 people per 100 thousand people. It is proved that Ukraine had the highest rates (%) of changes in these 
indicators, compared to other countries. Thus, the average value of the growth rate (%) of this indicator in Ukraine was 15.0 %, in 
Belarus and the CIS countries – 9.0 %, in Poland – 3.0 %, and in the ER of WHO – 4.0 %. It should be noted that in Ukraine, Belarus 
and Poland there was an unstable nature of changes in the number of graduates of pharmacists, per 100 thousand of us. According to 
the comparative analysis, it was found that the average value of the analyzed indicator in Ukraine was 5.8 times higher than in Belarus 
and 2.3 times higher than in Poland. In addition, the corresponding data of Ukraine were 3.1 and 2.6 times higher than similar indica-
tors calculated in the CIS and ER of WHO countries. It is also noteworthy that the decline in Ukraine was characterized only by one 
year (2010), and amounted to 3.0 %.
Conclusions. Against the background of a systematic increase in the number of graduates-pharmacists who received diplo-
mas in higher educational institutions of Ukraine, it is promising to analyze the dynamics of changes in the number of specialists 
who are actively engaged in professional activities in the pharmaceutical system. Confirming the status of a pharmaceutical country, 
in our opinion, Ukraine should form a socially oriented profile of the human resources potential of the health care system among the 
ER countries of WHO.
Keywords: graduates-pharmacists, staff of the system of pharmaceutical support of the population, personnel potential, 
system of pharmaceutical support of the population, pharmacist.
DOI: 10.21303/2504-5679.2021.001566
1. Introduction
In recent years, the public health system has undergone significant changes that have affected 
virtually all areas of activity. Particularly acute influence of various external factors was felt by so-
cially-oriented industries, namely the system of pharmaceutical supply and its important component – 
the market of drugs and other products of the pharmaceutical range [1, 2]. The introduction of socially 
oriented forms and methods of pharmaceutical services is currently considered in the vast majority 
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of countries as a priority for the development of national health care systems [3, 4]. Ukraine is no 
exception to this list of countries, which since independence in 1991 has undergone a difficult path of 
development in the direction of health care in general and the pharmaceutical supply system in parti-
cular [5, 6]. The pharmaceutical supply systems of European countries have also undergone a diffi-
cult path of development, which at the end of the last century began an active path to the introduction 
of socially oriented forms and methods of public service and health care reform in general [7, 8]. 
In the pharmaceutical market, many interests intersect, from legal and purely commercial, 
to moral, ethical and psychological [9, 10]. Effective implementation of the social burden, which 
is increasing every year in the pharmaceutical market, requires employees of pharmacies to con-
stantly acquire new knowledge and skills [11, 12]. In addition, as a result of the radical changes that 
have taken place in pharmacy at the turn of the century, the role of pharmaceutical workers has ac-
quired a fundamentally new meaning and vision of development in the health care system [13, 14]. 
At present, pharmacies and pharmaceutical workers are no longer considered as passive subjects of 
relations in the health care system [15, 16]. Every year their role is transformed, and professional 
and social influence increases [13, 17]. In turn, the level of social influence on the pharmaceutical 
supply system increases every year, and the drug market forms new requirements for professionals 
in a wide range of their competencies for practical skills [18].
Against the background of intensified development of European integration processes in the 
country, the issue of forming human resources of such an important, from a socio-economic point 
of view of the macroeconomic complex of the state, which is the system of pharmaceutical supply, 
is relevant. This determined the aim of our research. 
The aim. Identification of the main characteristics and development trends of the process 
of forming the human resources system of the pharmaceutical system in Ukraine, Belarus, Poland, 
the countries of cooperation of the Independent States (CIS) and the European Region (ER) of the 
World Health Organization (WHO). 
2. Materials and methods 
The objects of the study were data, presented on the European Health Information Por-
tal («Information and Facts»). The indicators of the total number of graduates-pharmacists and in 
terms of 100 thousand population in Ukraine, Belarus, Poland, the CIS countries and the ER of 
WHO during 2000–2013 were studied.
The content of the indicator «number of pharmaceutical graduates in terms of 100 thousand 
population» according to the European Health Information Portal is as follows:
– It is a part of the general indicator with the indicator of the name «Pharmacists engaged in 
practical professional activity, all». Number of pharmaceutical graduates per 100,000 population.
– The indicator is presented on the site in accordance with the code: grad.pharm.rate.
– Defined as the total number of students who received a diploma with a formal qualifica-
tion in the relevant year.
– Link to relevant WHO data: https://gateway.euro.who.int/ru/indicators/hlthres_154-phar-
macists-graduates-per-100-000/. Data are presented at the end of the calendar year. The last update 
of WHO data took place on September 20, 2016.
For the convenience of the analysis, the number of pharmaceutical graduates per 100 thou-
sand population received a symbol – indicator A. The analysis of the dynamics of change was con-
ducted from 2000 to 2013. It should be noted that the European database on human and technical 
resources of health care (HlthRes- DB) contains statistics on 200 indicators from 53 countries [19]. 
The latest data presented on the information portal dates back to 2013–2014.
An important step in conducting these studies was to determine the group of reference 
countries. In the process of selecting countries for comparison, we used the following statements: 
– the election of a country which, according to the parameters of historical and socio-eco-
nomic development, has for a long time been in the same conditions as Ukraine;
– the need to take into account the intensification of European integration guidelines for the 
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Thus, we have selected for comparison such countries and associations as Belarus, Poland, 
the CIS countries and the ER countries of WHO. 
Methods for analyzing the dynamics of interval complete series were used. As you know, 
in complete series, dates or periods follow each other at regular intervals. We calculated growth 
rates (%) and growth (%), as well as chain values of growth/decrease coefficients (kkn+1). In addi-
tion to chain indicators, we also calculated the basic (comparison to the first period in time) data to 
the indicators of 2000. The range of fluctuations of indicators was determined using the variation 
of the data (R = Nmax–Nmin), as well as in %, as the ratio of the range of fluctuations to Nmin [19].
All required indicators were processed using the standard statistical analysis package Statis-
tica (version 12.0, StatSoft, Tulsa, USA). In statistical calculations, the value of p < 0.05 was con-
sidered statistically significant.
Historical, information-analytical, analytical-comparative, systemic, logical, hypothetical- 
deductive and generalizations, as well as mathematical-statistical research methods are used.
3. Research results
According to the results of research, we can say the following. In 2000, the indicator A in 
Ukraine, Poland and ER countries of WHO ranged from 2.61 to 2.63 people per 100 thousand people. 
The lowest value of indicator A was observed in Belarus, and in general in the CIS countries it was 
equal to 1.72 people per 100 thousand people. That is, Ukraine at the beginning of the observation 
period had the closest to European values indicator A. Later, the dynamics of this indicator showed 
an increase in a significant range of values.
Thus, in Ukraine, a systematic increase in data from 2.61 to 14.49 people per 100 thousand 
people observed during 2000 and 2013 and increased 5.6 times. For comparison, in Belarus this in-
dicator increased only 2.7 times, in Poland – 1.3 times, in the CIS countries as a whole – 2.8 times, 
and in the ER countries of WHO – 1.6 times. 
The variation range of domestic indicators A was equal to 11.88 or 455.2 %. The highest 
growth rates (+35.0 %) of indicators A in Ukraine are observed in 2005 (indicator A increased from 
5.89 to 7.93 persons per 100 thousand people).
It should be noted that in Ukraine every year there was an increase in indicator A at diffe-
rent rates (%), the only exception is the data for 2010. Thus, this year the indicator A, compared to 
the previous 2009 decreased by 3.0 %. In general, it should be noted that in comparison with other 
countries, Ukraine was characterized by the highest values of indicators A for all years of the study 
(except for data on Belarus in 2001 and the CIS countries in 2002), as well as growth rates (%) data. 
The latter ranged from 3.0 % to 35.0 %, but in general, the dynamics of indicators was unstable and 
can be described as «wavy».
It is noteworthy that in Belarus, indicator A had the lowest data compared to other countries. 
Thus, the indicator A ranged in the range of values from 0.69 (2000) to 2.02 people per 100 thou-
sand people (2010), i.e. the variation range was equal to 1.33 or 192.8 %. The maximum growth 
of indicators was typical for 2001 (+52.0 %). At the same time, a decrease in data compared to the 
previous period was observed in 2004 (–5.0 %), 2009 (–11.0 %), 2011 (–7.0 %) and in 2013 (–1.0 %). 
That is, it can be argued that in Belarus, the dynamics of indicator A was extremely unstable 
in retrospect. The results of the comparative analysis are shown in Table 1.
In Poland, the indicator A ranged from 2.55 (2005) to 3.37 people per 100 thousand 
people (2011). The variational range was only 0.82 or in % it was 32.16 %. For example, for Ukraine, 
a similar statistic was 455.17 %. The maximum increase (+20.0 %) was observed in Poland accord-
ing to 2006 data, and a decrease was observed in 2001 (–1.0 %), 2005 (–10.0 %). 2009 (–1.0 %), 
2010 (–3.0 %), 2012 (–6.0 %). That is, it can be argued that in Poland, as in Belarus, there was an 
unstable nature of changes in indicators A in retrospect.
Analyzing the data in Table 1, we can say that the indicator A in the CIS countries ranged 
from 1.72 (2000) to 4.90 people per 100 thousand people (2013), i. e. the range of variation was 
3.18 or 184.9 %. Maximum growth (+45.0 %) indicator A according to the data of 2002. Thus, this 
indicator increased from 1.88 to 2.72 persons per 100 thousand people. The decline in data relative 
to previous values was observed in 2004 (–1.0 %) and 2010 (–4.0 %). 
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Table 1
The results of a comparative analysis of changes in indicators A in the dynamics of years
Years
Analysis indicator A
Ukraine Belarus CIS countries Poland ER countries of WHO 
А1 k1+n А2 k1+n А3 k1+n А4 k1+n А5 k1+n
2000 2.61 – 0.69 – 1.72 – 2.61 – 2.63 –
2001 2.85 1.09 1.05 1.52 1.88 1.09 2.58 0.99 2.61 0.99
2002 3.66 1.28 1.14 1.09 2.72 1.45 2.65 1.03 2.91 1.11
2003 4.72 1.29 1.52 1.33 3.55 1.31 2.83 1.07 3.44 1.18
2004 5.89 1.25 1.45 0.95 3.50 0.99 –* –* 3.24 0.94
2005 7.93 1.35 1.47 1.01 4.35 1.24 2.55 0.90 3.38 1.04
2006 9.56 1.21 1.55 1.05 4.42 1.02 3.05 1.20 3.55 1.05
2007 10.72 1.12 1.68 1.08 4.81 1.09 3.11 1.02 3.59 1.01
2008 12.94 1.21 –* –* 4.85 1.01 3.29 1.06 3.71 1.03
2009 12.94 1.00 1.50 0.89 4.85 1.00 3.24 0.99 3.84 1.04
2010 12.54 0.97 2.02 1.35 4.65 0.96 3.13 0.97 3.87 1.01
2011 12.91 1.03 1.87 0.93 4.65 1.00 3.37 1.08 3.9 1.01
2012 13.26 1.03 1.87 1.00 4.77 1.03 3.17 0.94 4.19 1.07
2013 14.49 1.09 1.86 0.99 4.90 1.03 3.36 1.06 4.27 1.02
Av. val. 9.07 1.15 1.57 1.09 3.97 1.09 2.91 1.03 3.51 1.04
Note: * – data on the site are missing
In the ER countries of WHO, indicator A was measured in the range of values from 
2.61 (2002) to 4.27 persons per 100 thousand people (2013). Thus, the magnitude of the variation of 
the indicators was equal to 1.66 or 63.60 %. The highest growth rate was typical for 2003, namely 
+18.0 %. In turn, a slight drop in data was typical for 2001 (–1.0 %) and 2004 (–6.0 %). Thus, it can 
be argued that in the CIS and ER countries of the WHO in comparison with Ukraine, Belarus and 
Poland, there was a more stable dynamics of changes in indicators A.
The next stage of our research was a comparative analysis of the average values of indicator 
A and the rate (%) of its growth by country. It was found that the average value of growth rates (%) 
of indicators A in Ukraine was 15.0 %, in Belarus and the CIS countries – 9.0 %, Poland – 3.0 %, 
and in the ER countries of WHO – 4.0 %. As can be seen, the domestic indicators characterizing 
the dynamics of changes in the analyzed data are 1.7 times higher than in Belarus and the CIS 
countries, and 5.0 and 3.8 times higher than the corresponding data in Poland and the ER countries 
of WHO. The results of the analysis of average indicators A by group of reference countries are 
presented in Fig. 1. 
Fig. 1. The results of a comparative analysis of the average values of indicator A  
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According to the results of the analysis, the average value of indicator A in Ukraine is 
5.8 times higher than in Belarus and 2.3 times higher than in Poland. Comparing the domes-
tic average data with the group of CIS and ER countries of WHO, it can also be stated that the 
Ukrainian data were 3.1 and 2.6 higher than similar data in the CIS and ER countries of WHO, 
respectively. 
4. Discussion of results
Based on the generalization of the results of the research, it can be stated that Ukraine 
has consistently held a leading position in the number of graduates-pharmacists (indicator A). 
During the studied years in Ukraine, there was a steady increase in the number of graduates who 
received appropriately diplomas from pharmacists, which was characterized by incomparably 
higher growth rates (%) compared to other countries included in the analysis. The dynamics of 
the number of graduates (pharmacists, pharmacists) who received diplomas in Ukraine, Belarus 
and Poland, according to the European Health Information Portal WHO is presented in Fig. 2. 
It should be noted that these data on the CIS and ER countries of WHO, unfortunately, were 
not available.
Fig. 2. Analysis of the dynamics of indicators A (total number of graduates) in Ukraine, Belarus 
and Poland during 2000–2013 according to the WHO
Thus, taking into account the results of the research, it can be argued that Ukraine can 
reasonably consider itself a pharmaceutical country, especially in the direction of training relevant 
specialists for the health care system. At the same time, it should be noted that the nature of the 
changes in the studied indicators is unstable compared to similar data observed in the CIS and ER 
countries of WHO, which requires further research in this area.
This approach provides an opportunity to qualitatively assess the effectiveness of training 
future professionals for the pharmaceutical supply system in retrospect. 
Study limitations. Carrying out research in the specified direction, it is necessary to 
note the following restrictions in use of the received results. First, the studies were limited to 
a certain period of time after which WHO provided country data on the official website of the 
European Information Portal. It should be noted that this limitation was objective in nature and 
was taken into account by us in the design of the research. Secondly, given the retrospective na-
ture (2000–2013) of the obtained data, their practical use may currently be limited. Since 2013, 
significant changes have taken place in the educational space of the reference countries in the 
direction of training pharmaceutical personnel. Nevertheless, the main trends and the nature of 
changes in indicators outlined by us allowed, in general, to assess the state of development of the 
analyzed process. 
Prospects for further research. In our opinion, a comparative analysis of the dynamics of 
changes in indicator A and the total number of specialists working in pharmacies of various forms 
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5. Conclusions
1. On the basis of the conducted researches it is determined that during 2000–2013 
in Ukraine there was a significant increase in these indicators of the number of pharmaceutical 
graduates in terms of 100 thousand population, from 2.61 to 14.49 people per 100 thousand people. 
That is, at the beginning of the observation period, Ukraine had the closest to European values 
indicator A, and later its growth had the highest rate (%) by group of reference countries.
2. It was found that Ukraine had the highest rate of change in indicator A. It was found that 
the average growth rate (%) of indicators A in Ukraine was 15.0 %, in Belarus and the CIS – 9.0 %, 
Poland – 3.0 %, and in the ER countries of WHO – 4.0 %.
3. It is established that the decrease in the relevant indicators, compared to the data of the 
previous period, was typical for Ukraine only for one year (2010, data drop -3.0 %). For example, in 
Belarus, a decrease in A compared to previous data was observed for 5 years, in Poland – 4 years, 
and for the CIS and ER countries of WHO – 2 years.
4. Analyzing the dynamics of indicators A, it can be argued that the most stable nature of 
their changes was characteristic of the CIS and ER countries of WHO.
5. It is proved that the average value of indicator A in Ukraine was 5.8 times higher than 
in Belarus and 2.3 higher than according to data in Poland. In addition, the corresponding 
Ukrainian data were 3.1 and 2.6 times higher than similar figures calculated in the CIS and ER 
countries of WHO.
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